Literature DB >> 24024585

Treatment of seronegative spondyloarthropathy-associated uveitis with golimumab: retrospective case series.

Sepideh Faez1, Ann-Marie Lobo, Lucia Sobrin, George N Papaliodis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24024585     DOI： 10.1111/ceo.12207

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN： 1442-6404            Impact factor:   4.207


× No keyword cloud information.
  11 in total

Review 1.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 2.  Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.

Authors:  Claudia Fabiani; Antonio Vitale; Giuseppe Lopalco; Florenzo Iannone; Bruno Frediani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-09-30       Impact factor: 2.980

3.  Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.

Authors:  Robert J Barry; Mohammad O Tallouzi; Nick Bucknall; Jonathan M Mathers; Philip I Murray; Melanie J Calvert; David J Moore; Alastair K Denniston
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

Review 4.  New Immunosuppressive Therapies in Uveitis Treatment.

Authors:  Salvador Mérida; Elena Palacios; Amparo Navea; Francisco Bosch-Morell
Journal:  Int J Mol Sci       Date:  2015-08-11       Impact factor: 5.923

Review 5.  Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Biologics       Date:  2014-02-15

Review 6.  The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future.

Authors:  Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Elisabetta Miserocchi; Ennio Giulio Favalli
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

7.  A case of human leukocyte antigen B-27-associated ocular hypotony successfully treated with golimumab.

Authors:  Parthopratim Dutta Majumder; Ruchika Lakra; G Yamuna; Anindya Kishore Majumder; Viswanath Kaushik
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

8.  Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials.

Authors:  Damien Roche; Martin Badard; Laurent Boyer; Pierre Lafforgue; Thao Pham
Journal:  Arthritis Res Ther       Date:  2021-07-16       Impact factor: 5.156

9.  Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience.

Authors:  Miguel Cordero-Coma; Vanesa Calvo-Río; Alfredo Adán; Ricardo Blanco; Carolina Álvarez-Castro; Marina Mesquida; Sara Calleja; Miguel A González-Gay; José G Ruíz de Morales
Journal:  Mediators Inflamm       Date:  2014-05-28       Impact factor: 4.711

Review 10.  Pharmacotherapy for uveitis: current management and emerging therapy.

Authors:  Robert J Barry; Quan Dong Nguyen; Richard W Lee; Philip I Murray; Alastair K Denniston
Journal:  Clin Ophthalmol       Date:  2014-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.